Faculty Information |
|
Article types | Original article |
Language | English |
Refereed paper | Refereed |
Title | Comparison of prognostic impact of atezolizumab plus bevacizumab versus lenvatinib in patients with intermediate-stage hepatocellular carcinoma |
Journal | Formal name:Liver international : official journal of the International Association for the Study of the Liver Abbreviation:Liver Int ISSN code:14783223/14783231 |
Domestic / Foregin | Foregin |
Volume, Number, Page | 44(1),pp.113-124 |
Papers・Author | Tada Toshifumi, Kumada Takashi, Hiraoka Atsushi, Kariyama Kazuya, Tani Joji, Atsukawa Masanori, Takaguchi Koichi, Itobayashi Ei, Fukunishi Shinya, Tsuji Kunihiro, Ishikawa Toru, Tajiri Kazuto, Ochi Hironori, Yasuda Satoshi, Toyoda Hidenori, Ogawa Chikara, Nishimura Takashi, Hatanaka Takeshi, Kakizaki Satoru, Shimada Noritomo, Kawata Kazuhito, Tada Fujimasa, Ohama Hideko, Nouso Kazuhiro, Morishita Asahiro, Tsutsui Akemi, Nagano Takuya, Itokawa Norio, Okubo Tomomi, Arai Taeang, Imai Michitaka, Kosaka Hisashi, Naganuma Atsushi, Matono Tomomitsu, Aoki Tomoko, Kuroda Hidekatsu, Yata Yutaka, Koizumi Yohei, Nakamura Shinichiro, Kaibori Masaki, Iijima Hiroko, Hiasa Yoichi, Kudo Masatoshi, Real-life Practice Experts for HCC (RELPEC) Study Group and the Hepatocellular Carcinoma Experts from 48 clinics in Japan (HCC 48) Group |
Publication date | 2024/01 |